Table 5.
Study | Country | Age Group | Year | Prevalence or incidence* per 1000 |
---|---|---|---|---|
Kurtz et al [25] | England | 0-23 | 1998 | 8.4* |
Eriksson et al [26] | Finland | 0-15 | 1992 | 3.9 |
Karabiber et al [10] | Malatya (Turkey) | 7-12 | 2001 | 8.0 |
Singh et al [27] | India | 6-15 | 1997 | 4.2 |
Endziniene et al [28] | Lithuania | 0-15 | 1995 | 4.3 |
Beilmann et al [29] | Estonia | 5-9 | 1999 | 4.3 |
Waaler et al [30] | Norway | 6-12 | 2000 | 5.1 |
Aziz et al [31] | Pakistan | 0-10 | 1997 | 9.98 |
Aziz et al [31] | Turkey | 0-10 | 1997 | 7.0 |
Wong V [20] | Hong Kong | <19 | 2004 | 4.3 |
Sidenvall et al [21] | Switzerland | 0-16 | 1996 | 4.2 |
Serdaroğlu et al [9] | Turkey | 0-16 | 2004 | 8.0 |
Banerjee et al [6] | India | ≤19 | 2003-4 | 7.0 |
Prischich F et al [7] | Cameroon | 10-19 | 2004 | 26.1 |
Present study | Trabzon / Turkey | 0-17 | 2007 | 8.6 |